Darenzepine
Modify Date: 2024-01-19 19:17:00
Darenzepine structure
|
Common Name | Darenzepine | ||
|---|---|---|---|---|
| CAS Number | 84629-61-8 | Molecular Weight | 347.41000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H21N3O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DarenzepineDarenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1. |
| Name | 6H-Dibenz[b,e]azepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)-2-oxoethylidene]-, (11E) |
|---|---|
| Synonym | More Synonyms |
| Description | Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1. |
|---|---|
| Related Catalog | |
| Target |
muscarinic receptor[1] |
| In Vitro | Darenzepine is a muscarinic receptor inhibitor which is useful for the treatment of CNS disorders[1]. |
| References |
| Molecular Formula | C21H21N3O2 |
|---|---|
| Molecular Weight | 347.41000 |
| Exact Mass | 347.16300 |
| PSA | 56.41000 |
| LogP | 1.39270 |
| Storage condition | 2-8℃ |
| Darenzepine |
| 11H-Dibenz[b,e]azepine, piperazine deriv. |
| DARENZEPINE |
| Piperazine, 1-[(5,6-dihydro-6-oxo-11H-dibenz[b,e]azepin-11-ylidene)acetyl]-4-methyl-, (E)- |